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ABSTRACT 
Non-alcoholic fatty liver disease (NAFLD) patients have alteration in hemostasis components. Thus, including excess 
expression of plasminogen activator inhibitor-1 (PAI-1), causing fibrinolysis disorders; the majority of these patients are 
hypercoagulable state prone to thrombosis. Some evidence suggests that garlic and garlic supplements have antithrombotic 
and anti-inflammatory properties. Besides, garlic stimulates fibrinolytic activity and normalizes plasma lipid imbalances. 
Black garlic is processed garlic that is produced through natural aging at a controlled temperature (70 °C) and high 
humidity (90%) for several days, without other additives. This study aimed to prove the effect of single clove black garlic 
(SCBG) (Allium sativum Linn) on PAI-1 levels and lipid profiles of NAFLD rats induced by a high-fat fructose diet 
(HFFD) containing 1.25% cholesterol and 0.5% cholic acid.The rats were then divided into healthy control group (K1+); 
NAFLD control group without treatment (K2+); 0.9 mg simvastatin treatment group (K1-); 45 mg metformin treatment 
group (K2-); SCBG 450 mg per 200g BW (X1); 900 mg per 200 g BW (X2); and 1350 mg per 200 g BW (X3). All 
treatments were administered for 4 weeks via oral gavage. As a result, significant differences in PAI-1 levels and lipid 
profiles between groups after the administration (p = 0.001) were noted and also by simvastatin and metformin, 
respectively. There was a correlation between PAI-1 and lipid profile of SCBG treatment. In conclusion, the administration 
of SCBG (1350 mg per 200 g BB per day) for 4 weeks had a significant effect on PAI-1 levels, and the lipid profiles in 
Sprague Dawley rats modeled NAFLD (p = 0.001). SCBG has provided benefits that can be useful in the management of 
NAFLD but it’s not equivalent to medicine. 
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INTRODUCTION 
 Several mechanisms have been described for the 
development of atherosclerosis in patients with NAFLD, 
including genetic predisposition, insulin resistance, and 
atherogenic dyslipidemia, oxidative stress, chronic 
inflammation, decreased adiponectin levels, and altered 
pro- and anticoagulant factor production, which are all 
present simultaneously (Francque, van der Graaff and 
Kwanten, 2016). NAFLD, especially in its necro 
inflammatory form (NASH), can cause atherogenic 
dyslipidemia (Kim et al., 2012). Also, an increase in 
procoagulant factors, such as fibrinogen, plasminogen 
activator inhibitor-1 (PAI-1), and tumor growth factor, all 
of which increase the risk of atherosclerosis, has been 
noted (Alkhouri et al., 2010). 
 To manage NAFLD, lifestyle modifications are strongly 
suggested, especially dietary arrangements. However, 
patients usually fail to achieve these changes because they 
are unable or unwilling to change their dietary habits, they 
require safe and effective diet management for them. 
Garlic (Allium sativum L.) is a functional food containing 
an allyl-substituted sulfur compound that has been used for  
a long time both for seasoning and also for prevention and 
cure of diseases in many cultures (Rivlin, 2001). 
Preclinical and clinical studies suggest a link between 
dietary habits and disease occurrence. Previous studies 
have shown that garlic consumption is inversely correlated 
to the incidence of hyperlipidemia, atherosclerosis, and 
thrombosis (Agarwal, 1996). Garlic has many health 
benefits, but its raw form is not always consumed, because 
it has a strong odor and taste due to its organosulfur 
compounds, which makes some people uncomfortable. In 
recent years, various methods of processing raw garlic 
have been used, such as fermentation and heating for  
a long time, which eliminates pungent odors, imparts  
a sweet taste, and increases the beneficial effects (Bae et 
al., 2014). Black garlic is processed garlic that is produced 
through natural aging at a controlled temperature (70 °C) 
and high humidity (90%) for several days, without other 
additives (Toledano-Medina et al., 2019). Through 
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processing, the S-allyl-L-cysteine content in black garlic 
becomes up to five times higher (Sasaki et al., 2007). 
Also, black garlic had a higher polyphenol content and 
SOD activity and scavenging activity against hydrogen 
peroxide were stronger than raw garlic (Kim et al., 2012; 
Sato, Kohno and Niwano, 2006). The cardiovascular 
benefits of black garlic administration have been 
illustrated in various studies. However, so far, few studies 
have been done on the effect of SCBG administration on 
PAI-1 levels and lipid profiles in NAFLD. In this study, 
we evaluated the effective administration of SCBG, 
simvastatin, and metformin on the hemostasis status and 
lipid profiles of rats modeled NAFLD induced by a high-
fat fructose diet (HFFD) containing 1.25% cholesterol and 
0.5% colic acid. 
 
Scientific hypothesis 
 We investigate several hypotheses in our study: 
1. The administration of SCBG at different doses 
(450 mg per 200 g BW per day;  
900 mg per 200 g BW per day and 1350 mg 
per 200 g BW per day) for 4 weeks have  
a significant effect on PAI-1 levels, and lipid 
profiles of Sprague Dawley rats modeled 
NAFLD compared with simvastatin and 
metformin treatment groups. 
2. There are correlations between PAI-1 and 
Lipid Profiles of Sprague Dawley rats modeled 
NAFLD. 
 
MATERIAL AND METHODOLOGY 
 This study was part of the research project entitled Study 
of Pre-clinical Benefit of Black Garlic (Allium sativum 
Linn) in Non-alcoholic Fatty Liver Disease (NAFLD). 
Samples 
 This study used Rattus norvegicus, strain  Sprague 
Dawley rats, weighing 180 – 200 g and aged  
8 – 10 weeks old. 
Chemicals 
	 Plasma PAI-1 levels were determined using Rat PAI-1 
ELISA kit, Finetest from Wuhan Fine Biotech Co. Ltd. 
Lipid profiles were determined using Cholesterol FS (10’) 
5 x 25 mL/1x 3 mL Standard, Triglycerides FS (10’)  
5 x 25 mL/1 x 3 mL Standard, HDL Precipitant  
250 mL, LDL Precipitant 250 mL from DiaSys, Holzheim, 
Germany. 
Animals and Biological Material: 
 The male Sprague Dawley rats (n = 42) were purchased 
from the Center of the Food and Nutrition Studies of 
Gadjah Mada University, Yogyakarta, Indonesia. An 
acclimatization period lasting seven days was scheduled 
before the beginning of the experiment. After the 
acclimatization period, rats were divided into seven groups 
(n = 6 per group): healthy rats given standard feed (K1+), 
NAFLD rats without treatment (K2+); 0.9 mg simvastatin 
treatment group (K1-); 45 mg metformin treatment group 
(K2-); single clove black garlic (SCBG) 450 mg per 200 g 
BW (X1); 900 mg per 200 g BW (X2); and 1350 mg per 
200 g BW (X3). All animals, except the K1+ group, were 
fed a high-fat fructose diet (HFFD) containing cholesterol 
(1.25%) and cholic acid (0.5%) for 8 weeks. 
 The standard feed containing 15% crude protein,  
3 – 7% crude fat, 12% moisture content, 6% crude fiber, 
7% ash, 0.5% phosphorus, and 0.9 – 1.1% calcium, and 
vitamins. The composition of HFFD as follow was  
177.5 g.kg-1 pork oil, 172.8 g.kg-1 fructose, 19.87 kJ.g-1 
energy, 20% protein, 35% carbohydrates, and 45% fat. 
 Black garlic used in this study was produced from the 
Biotechnology Agency for Technology Assessment and 
Application (BPPT), Tangerang, Indonesia, with the 
commercial name of Natural Black Garlic® Lanang, 
which has passed the test of acute toxicity by the 
Laboratory Toxicity and Safety Materials, School of 
Pharmacy Bandung Institute of Technology, Indonesia. 
The main raw material for Natural Black Garlic® Lanang 
is single clove garlic. It's processed garlic that is produced 
through natural aging at a controlled temperature (70 °C) 
and high humidity (90%) for 26 days without other 
additives (Figure 1). 
Instruments 
 iMark™ microplate absorbance reader, Bio-Rad. 
Microprocessor Controlled Spectrophotometer, OPTIMA 
SP-300. 
Laboratory Methods 
 PAI-1 levels were measured using the Enzyme-Linked 
Immunosorbent Assay (ELISA) method (Crowther, 
2009). 
 Total cholesterol and HDL-C levels were analyzed by 
Cholesterol Oxidase- Phenol Amino Phenazone (CHOD-
PAP) and triglycerides were analyzed by Glycerol 
Phosphate Oxidase-Phenol Amino Phenazone (GPO-PAP) 
(McPherson and Pincus, 2016). LDL-C levels were 
calculated with the Friedewald formula. 
Description of the Experiment 
 Simvastatin, Metformin and Single Clove Black Garlic 
preparation as follows was 0.9 mg simvastatin and  
45 mg metformin per 200g BW as comparative groups and 
SCBG dose 450 mg, 900 mg, and 1350 mg per 200 g BW, 
respectively, were mashed and diluted together with 3 mL 
of aqua bidestilata (Hatton et al., 2015). All samples were 
administered by oral gavage (Atcha et al., 2010). 
Sample preparation: After 4 weeks of administration, all 
animals overnight fasted. Blood was collected from the 
sinus orbital (Wolforth, 2000) and centrifuged at  
1,000 rpm for 15 minutes at 2 – 8 °C, then plasma was 
collected and stored at -80 °C for later analysis. 
 Number of samples analyzed: forty-two. 
 Number of repeated analyses: duplo 
 Number of experiment replication: There is no 
experiment replication in our study. 
 
Statistical Analysis 
 Bodyweight gain was recorded weekly, while 
examination data of PAI-1 levels and plasma lipid profiles 
were taken post-test. All data were analyzed statistically 
using IBM SPSS Statistics for Windows version  
22.0. Shapiro-Wilk test was used to test the normality of 
data. The analyses used were paired t-test, one-way 
ANOVA, post- hoc LSD, Kruskal-Wallis, and Mann-
Whitney. For the correlations between PAI-1 levels and 
lipid profiles used correlation Spearman test. 
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RESULTS AND DISCUSSION 
 In this study, the HFFD containing cholesterol (1.25%) 
and cholic acid (0.5%) – supplied rats showed marked 
obesity (increases of body weight), hyperlipemia 
(increases of the plasma total cholesterol, triglyceride, and 
LDL-C levels with decreases of the HDL-C levels) and 
hemostasis status (increases of PAI-1 level). Overall, 
obesity, diabetes, and hyperlipemia were induced by  
8 weeks of continuous HFFD supply, which is consistent 
with the findings of previous studies (Abe et al., 2019; 
Jarukamjorn et al., 2016; Oligschlaeger and Shiri-
Sverdlov, 2020). Administration of HFFD containing 
cholesterol (1.25%) and cholic acid (0.5%) aim to induced 
fatty liver in experimental animals. HFFD content is 
considered the same as a fast-food diet which contains 
high fat, high fructose, and high cholesterol (i.e. 2% w/w). 
Free fatty acids are known to trigger mitochondrial 
dysfunction, oxidative stress, and hepatic stellate cell 
activation. Fructose is known to be a major activator of 
lipotoxicity factors in the liver, leading to the development 
of NAFLD. Fructose consumption was found to be higher 
in patients with NAFLD compared to controls of the same 
age, and increased fructose consumption has been 
associated with the severity of fibrosis in patients with 
NAFLD (Abe et al., 2019). Free cholesterol directly 
activates liver stellate cells, besides that high cholesterol in 
the composition of the fast-food diet also promotes the 
development of nonalcoholic steatohepatitis (NASH) 
(Tomita et al., 2014). Thus, we conclude that excess 
amounts of fat, fructose, and cholesterol in HFFD 
exacerbate the lipotoxic environment and accelerate the 
progression of steatohepatitis and fibrosis in obese 
Sprague Dawley rats. 
 
Administration of HFFD against weight 
 After administration of HFFD containing cholesterol 
(1.25%) and cholic acid (0.5%) for 8 weeks, generally, the 
six groups of rats experienced an increase in body weight 
as well as the healthy group that was given standard feed. 
Weighing the rats was performed weekly starting from the 
acclimatization until the end administration of HFFD. 
Weighing the mice after acclimatization aimed to ensure 
that the experimental animal still within the inclusion 
criteria, namely, having a bodyweight of 150 – 200 g. 
Table 1 shows the changes in body weight of rats before 
and after conditioning. These changes probably due to the 
HFFD administration for 8 weeks during conditioning. 
HFFD containing high-fat (45%) and high-fructose  
(172.8 g.kg-1 diet), contributing a lot of energy  
(19.87 kJ.g-1) (Jung et al., 2011). Fat also contains high 
energy compared to carbohydrates and protein. 1 g of fat is 
equivalent to 9 kcal of energy, while 1 g of protein and 
carbohydrates each is equivalent to 4 kcal of energy 
(Hardinsyah and Supariasa, 2019). 
 In this study, the body weight of the animals significantly 
increased after HFFD administration in six group 
treatments (p = 0.001). except for the healthy group, which 
had an increase but not significant. The X2 group does not 
have significant weight differences before and after 
conditioning. In this study, the administration of HFFD 
attempted to apply the diet composition of NAFLD 
patients. The difference in food intake before and after 
HFFD administration between groups was related to the 
differences in the energy composition of the diets of 
different rats. The dietary intake of 15 g per rat per day 
was selected according to the nutritional needs of 
laboratory animals, which is considered the minimum 
amount needed by rats per day to ensure normal growth of 
them (Fakhoury-Sayegh et al., 2015). 
 
Effect of single clove black garlic on body weight 
 In this study, the increases of weights were meaningfully 
and dose-dependently inhibited by treatment of SCBG and 
also by simvastatin and metformin, respectively. The  
X2 and X3 groups experienced a change in obesity status 
after the SCBG administration. The SCBG group with 
doses of 900 mg and 1350 mg per 200 g BW per day had  
a preventive effect on obesity, which had no statistical 
difference from the healthy group. Meanwhile, the group 
of SCBG 450 mg per 200 g BW per day only had  
a slightly reduced Lee index, so they were unable to 
change the obesity status of the rats to normal (Table 2). 
 HFFD feeding in this study aimed to induce a fatty liver 
in rats. The excess consumption of carbohydrates (fructose 
and sucrose) and fat (fatty acids and cholesterol) plays  
a key role in the development and advancement of obesity-
related NAFLD through the activation of the lipid 
metabolism pathway modulated on a high-fat diet 
(Jarukamjorn et al., 2016). 
 The obesity status of the X2 and X3 groups had changed 
after the SCBG administration. The treatment group of 
SCBG 900 mg per 200 g BW per day and 1350 mg per 
200 g BW per day provided a preventive effect of obesity 
and had no statistical difference from the healthy group. 
Meanwhile, the group of rats given SCBG 450 mg per  
200 g BW did not reduce the Lee index. Garlic is a rich 
source of polyphenol compounds and is highly potent in 
inhibiting lipid peroxidation. Polyphenols have the 
potential to prevent obesity by inhibiting enzymes related 
to lipid metabolism, for example, pancreatic lipase, 
lipoprotein lipase, and glycerophosphate dehydrogenase, 
or by regulating lipid homeostasis, for example, by 
regulating lipogenesis and fatty acid oxidation (Chen et 
al., 2014). In conclusion that black garlic has 
 an antiobesity effect (Chang, Wu and Hsu, 2015; Chang 




 PAI-1 level was measured once at the end of the study. 
The post-hoc LSD test showed significant differences  
in the PAI-1 levels in all groups of rats (p = 0.001). The 
PAI-1 levels were meaningfully and dose-dependently 
decrease by treatment of SCBG and also by simvastatin 
and metformin, respectively. It compared to the NAFLD 
group, without SCBG treated. However, when compared 
with the healthy group, the PAI-1 levels in the three 
treatment groups had not yet reached their PAI-1 levels 
(Table 3). 
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 Table 1 Effect of single clove black garlic on  body weight of rats modeled NAFLD. 
Groups Rats weight (g) P Acclimatization Conditioning Administration Δ1 Δ2 
Controls      
Healthy Rats 163.33 ±3.55 208.83 ±3.60a 238.16 ±4.35a 45.50 ±1.22a 29.33 ±2.25 0.005 
NAFLD Rats 164.83 ±2.56 242.50 ±2.26a 305.16 ±2.56a 77.67 ±0.81a 62.66 ±1.63a 0.004 
Reference      
Simvastatin 164.00 ±3.84 241.50 ±3.73a 271.33 ±3.38ab 77.50 ±1.04a 31.70 ±0.98b 0.002 
Metformin 163.33 ±2.80 240.16 ±3.43a 271.30 ±3.40bc 76.83 ±0.98a 31.16 ±1.98b 0.001 
SCBG treated      
X1 166.33 ±4.13 244.00 ±4.43a 284.33 ±4.63abcd 77.66 ±1.03a 40.33 ±1.81ac 0.001 
X2 165.17 ±2,32 242.33 ±2.58a 272.66 ±3.14abe 77.16 ±1.60a 30.33 ±2.73ab 0.061 
X3 163.00 ±2.83 240.33 ±2.42a 270.66 ±3.66abe 77.33 ±0.81a 30.33 ±1.50be 0.002 
p* 0.538 0.001 0.005* 0.001* 0.001*  
Note: Values are expressed as mean ± SD of six rats. Healthy, normal control group; NAFLD, Nonalcoholic fatty liver 
disease control group without treatment; X1, SCBG 450 mg per 200 g BW; X2, 900 mg per 200 g BW; X3, 1350 mg 
per 200 g BW. Simvastatin and metformin were administrated at dose levels of 0.9 mg and 45 mg per 200 g BW, 
respectively. p* = paired t-test; p = one-way ANOVA test ; abcdef – different notation shows a significant difference with 
post-hoc LSD test. 
 
 Table 2 Effect of single clove black garlic on obesity status of rats modeled NAFLD. 
Groups Obesity Status (Lee index) p Conditioning Administration Δ 
Controls    
Healthy Rats 286.32 ±2.82a 287.82 ±3.40 1.50 ±1.55 0.028 
NAFLD Rats 319.30 ±5.73a 332.52 ±3.21a 13.22 ±6.75a 0.028 
Reference    
Simvastatin 323.80 ±5.62 290.55 ±3.27b -33.24 ±2.51a 0.028 
Metformin 320.19 ±7.86a 287.34 ±7.12b -32.85 ±2.69ab 0.028 
SCBG treated    
X1 321.14 ±6.72a 302.76 ±4.90abcd -18.38 ±3.68abcd 0.028 
X2 318.98 ±4.13a 286.93 ±3.37be -32.04 ±1.04ab 0.028 
X3 318.67 ±8.94a 286.93 ±3.37be -34.21 ±4.11abe 0.028 
p* 0.009* 0.001* 0.001*  
Note: Values are expressed as mean ± SD of six rats. Healthy, normal control group; NAFLD, Nonalcoholic fatty liver 
disease control group without treatment; X1, SCBG 450 mg per 200 g BW; X2, 900 mg per 200 g BW; X3, 1350 mg 
per 200 g BW. Simvastatin and metformin were administrated at dose levels of 0.9 mg and 45 mg per 200 g BW, 
respectively. p = wilcoxon test ; p* = Kruskal-Wallis test; abcdef – different notation shows a significant difference with 
Mann-Whitney test. 
 







PAI-1 TC HDL-C LDL-C TG 
Controls     
Healthy Rats 1.03 ±1.11 96.17 ±2.94 80.73 ±1.97 25.87 ±2.30 74.56 ±2.94 
NAFLD Rats 30.86 ±1.26a 219.93 ±4.80a 24.47 ±2.32a 81.83 ±2.17a 142.44 ±4.75a 
Reference     
Simvastatin 4.02 ±3.32ab 117.47 ±3.90ab 64.54 ±2.98ab 41.16 ±1.88ab 95.45 ±2.12ab 
Metformin 2.98 ±1.68abc 114.94 ±4.57ab 66.78 ±3.09ab 34.54 ±2.06ab 94.78 ±2.92ab 
SCBG treated   
X1 6.84 ±0.22abcd 171.01 ±4.50abcd 36.05 ±3.43abcd 65.78 ±3.57abcd 118.21 ±2.66abcd 
X2 5.93 ±0.29abcde 133.33 ±5.63abcde 53.19 ±4.33abcde 40.79 ±1.75abde 106.56 ±3.32abcde 
X3 4.86 ±0.24abdef 121.07 ±2.78abef 61.35 ±2.32abdef 33.21 ±2.82abcef 98.39 ±1.95abef 
p 0.001* 0.001 0.001 0.001 0.001 
Note: Values are expressed as mean ± SD of six rats. Healthy, normal control group; NAFLD, Nonalcoholic fatty liver 
disease control group without treatment; X1, SCBG 450 mg per 200 g BW; X2, 900 mg per 200 g BW; X3, 1350 mg 
per 200 g BW. Simvastatin and metformin were administrated at dose levels of 0.9 mg and 45 mg per 200 g BW, 
respectively. p* = One way ANOVA test; p = Kruskal-Wallis test; abcdef – different notation shows a significant 
difference with Mann-Whitney test. 
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 Significant differences were noted in PAI-1 levels of all 
groups of rats (p = 0.001). The PAI-1 levels in the healthy 
group were significantly different from those in the 
NAFLD, simvastatin, metformin, X1, X2, and  
X3 groups. The SCBG dose of 1350 mg per 200 g BW 
more effectively improved the hemostasis status in 
NAFLD rats than 450 and 900 mg per 200 g BW 
respectively. 
 The consumption of HFFD appears to have contributed 
to NAFLD development and increased the risk of 
progression to NASH (Jarukamjorn et al., 2016), 
promote an increase in hemostasis status, namely, PAI-1 
level. In this study, X1, X2, and X3 groups had lower 
levels of PAI-1 than the NAFLD group (HFFD without 
SCBG administration). In this study, the biological 
substances of garlic and its processes, which are involved 
in the antithrombotic function, are unknown. Allicin, one 
of the main components in garlic, is known to have some 
biological activity, but it does not seem to promote a t-PA 
activity or reduce PAI-1 levels. Black garlic contains less 
allicin in the production process due to alliinase 
inactivation, so it is odorless. However, whether the alliin 
in the diet was converted to allicin after administered in 
rats and whether SCBG in our study had a specific 
antithrombotic activity are uncertain. As is known, garlic 
contains many physiological functions; the composition 
and amount of each element are responsible for various 
functions, which may differ between the types and 
methods of manufacture. It should be noted that the 
physiological function of garlic is not homogeneous and 
depends on the number of active components and their 
combinations in garlic processing (Fukao et al., 2007). 
Therefore, which components contribute to the 
antithrombotic activity in NAFLD rats is uncertain. In 
short, garlic greatly reduces the coagulation activity, which 
would prevent the formation of blood clots in the 
thrombus-modeled pathological rats. These results may 
explain the benefit of garlic and its preparations for blood 
and blood vessels. 
 In vitro and in vivo studies have shown that garlic 
appears to have antiplatelet, fibrinolytic, and 
antithrombotic effects, in addition to its anti-inflammatory 
properties (Chang et al., 2005; Teranishi et al., 2003). 
Garlic also reduced PAI-1 levels in obese subjects 
compared to the placebo group (Szulińska et al., 2018). 
Another study showed that administration of Methanolic 
Extract of Black Garlic (MEBG) reduced levels of PAI-1 
(p <0.05) in obese rats fed a high-fat diet (Chen et al., 
2014). Regarding the molecular regulation of decreased 
levels of PAI-1 and inhibition of adipogenesis in obese 
mice by black garlic supplementation through increased 
AMPK, forkhead box protein-01(FOXO1), Sirtuin-
1(Sirt1), adipose triglyceride lipase (ATGL), hormone 
sensitive lipase (HSL), perilipin, acyl-CoA-1 (ACO), 
carnitine palmitoyltransferase (CPT-1), and uncoupling 
protein-1(UCP1), thereby reducing lipogenesis, increasing 
lipolysis and fatty acid oxidation. The expression of cluster 
of differentiation-36 (CD36) levels decreased, resulting in 
less free fatty acid uptake in the adipose tissue. Also, black 
garlic increases adiponectin and downregulates PAI-1, 
resistin, tumor necrosis factor- α (TNF-α), and glucose 
transporter type-4 (GLUT4), thereby increasing insulin 
resistance in rats fed a high-fat diet (Chen et al., 2014). 
Similarly, the downregulates PAI-1 mechanism of 
simvastatin and metformin (Arruda de Faria et al., 2019; 
Mazza et al., 2012; Nascimbeni et al., 2016; Rodrigues, 
et al., 2019). 
 
Lipid profiles 
 In this study, the mean of total cholesterol (TC), high-
density lipoprotein-cholesterol (HDL-C), low-density 
lipoprotein-cholesterol (LDL-C), and triglycerides (TG) 
levels for all groups were significantly different  
(p = 0.001). After administration SCBG, the X1, X2, and 
X3 groups have a significant decrease in triglyceride levels 
(p = 0.001) compared to the NAFLD group  
(Table 3). 
 Consumption of high-fat diet results in the production of 
acetyl-CoA and malonyl CoA in the liver. Increased levels 
of malonyl CoA, as fuel for TG synthesis, will inhibit the 
expression of CPT-1, a key enzyme for lipolysis, thereby 
reducing fatty acid oxidation. As shown in this study, 
administration of HFFD and black garlic increases CPT-1 
mRNA expression; thus, more TG is broken down 
(degradation) to supply free fatty acids as an energy 
source, lowering plasma cholesterol concentrations 
associated with decreased HMG-CoA reductase expression 
and ACAT. SREBP-1c levels in the liver also activate the 
3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) 
reductase and acyl-CoA cholesterol acyltransferase 
(ACAT) enzymes, which regulate cholesterol synthesis 
and catalyze cholesterol esterification (Ha, Ying and 
Kim, 2015). 
 Calorie intake from fat and fructose promotes excess fat 
deposits in the adipose tissue. Excessive intake of fat from 
food will lead to an increase in lipogenesis activity and 
production of free fatty acids, resulting in the mobilization 
of free fatty acids from the fatty tissue to the liver and 
binding glycerol to form triglycerides. Giving a high-fat 
diet also increased levels of LDL and cholesterol in the 
circulation, triggering HDL to transport cholesterol from 
the liver to the circulation (reverse cholesterol transport). 
HDL is esterified into cholesterol esters, which can be 
taken directly to the liver then directly excreted or 
exchanged with triglycerides from VLDL and 
chylomicrons. When cholesterol ester excess, HDL-rich 
triglyceride (HDL low density) is breakdown by hepatic 
lipase resulting in lower circulating levels of HDL 
(Dissard et al., 2013; Wong et al., 2016). 
 The results showed that the mean of total cholesterol, 
HDL, LDL, and triglycerides levels for all groups were 
significantly different (p = 0.001). After  SCBG 
administration, the X1, X2, and X3 groups had lower 
triglyceride levels (p = 0.001) compared to the NAFLD 
group. These results supported the study of Seo et al. 
(2009) on db/db model rats given black garlic had lower 
triglycerides, cholesterol, fasting blood glucose, blood 
glycated hemoglobin levels, and higher HDL serum 
compared with rats with no black garlic intervention. 
 The lipid-lowering mechanism of black garlic in plasma 
and the liver of rats is described in Ha et al.’s study. 
They have measured the expression of liver SREBP-1c 
mRNA transcription factors’ key lipid metabolism and the 
decreased expression of SREBP-1c in rats fed extract 
black garlic, resulting in a decrease in liver sterol regulator 
element-binding protein-1c (SREBP-1c), Acetyl-CoA 
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carboxylase (ACC), fatty acid synthase (FAS), and  
G-6PDH mRNA levels, the target gene for SREBP-1c, 
indicating that the inhibition of the gene expression led to 
a decrease in the fat synthesis of the liver. 
 This is associated with a plasma TG concentration 
decrease. Similar results were reported: the methanolic 
extract Black Garlic (MEBG) administered in rats fed with 
a high-cholesterol diet inhibited lipid accumulation 
through adenosine monophosphate-activated protein 
kinase (AMPK) regulation and regulation of SREBP1c, 
ACC, and FAS (Ha, Ying and Kim, 2015; Sobenin et al., 
2019). Similarly, the lipid-lowering mechanism of 
simvastatin and metformin (Arruda de Faria et al., 2019; 
Mazza et al., 2012; Nascimbeni et al., 2016; Rodrigues 
et al., 2019; Sobenin et al., 2019). 
 Black garlic and its constituent, S-allyl-cysteine, had 
antioxidant and hypolipidemic effects in rats with a high-
fat diet (Asdaq, 2015). Therefore, the high concentration 
of S-allyl-cysteine in black garlic extract induced blood 
lipid profile changes in hepatic injury rats (Tran, Dam 
and Tram Le, 2018). These data support the results of this 
study in verifying the effect of single clove black garlic 
improving the lipid profile in NAFLD rats. 
 
Correlations between PAI-1 levels and lipid 
profiles 
 There were strong correlations between PAI-1 levels and 
lipid profiles, with r value = 0.76–0.99. The correlations 
were positive except for HDL-C levels  
(p = 0.001; r = -0.968), which means when HDL-C levels 
decrease, then the PAI-1 levels increase (Table 4). 
 Decreased plasma HDL cholesterol is the most common 
dyslipidemia in obese subjects and this condition is caused 
by hypertriglyceridemia, even if the levels are low or 
without elevated triglycerides. Hypertriglyceridemia is 
accompanied by a small increase in solid LDL, is highly 
atherogenic. The high concentration of non-esterified fatty 
acid (NEFA) released will be metabolized by the liver to 
increase the synthesis of liver triglycerides and very-low-
density lipoprotein (VLDL), thereby triggering insulin 
resistance. High circulating levels of VLDL reduce HDL 
concentrations and increase small solid LDL. 
Dyslipidemia is also accompanied by hyperactive platelets, 
hypercoagulability with increased factor VII, and 
hypofibrinolysis with increased PAI-1. High plasma 
triglyceride levels increase oxidative stress by increasing 
superoxide production. Increased NEFA from adipocytes 
increases tissue factor (TF) and PAI-1 levels and increases 
platelet aggregation; this condition causes thrombosis. 
Lipoprotein (a) levels in obesity are increased, especially 
when associated with hyperglycemia. Lipoprotein (a) has 
LDL-like properties and is structurally similar to 
plasminogen. It, therefore, inhibits the binding of 
plasminogen to endothelial cells and interferes with the 
generation of plasmin, both of which are atherogenic and 
thrombogenic. Prothrombin levels and levels of vitamin  
K-dependent coagulation factor are increased with 
hyperlipidemia (Darvall et al., 2007). 
 Significant correlations between PAI-1 levels and lipid 
profiles were noted in this study. Similarly, where  
a significant positive correlation was seen between PAI-1 
and triglyceride levels; on the other hand, PAI-1 and  





Total cholesterol 0.961 0.005 
HDL -0.968 0.001 
LDL 0.871 0.006 
Triglycerides 0.961 0.004    
Note: r = Spearman correlations. 
 
 
 Figure 1 Natural Black Garlic® Lanang Premium. 
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HDL-C levels showed a negative correlation in 
nondiabetic obese patients and the control group (Festa et 
al., 1999; Somodi et al., 2018). Besides, another study 
showed a strong and significant positive correlation 
between the most atherogenic LDL subfraction and the 
densest concentration of the PAI-1 plasma levels was also 
noted. This is the initial finding to evaluate the correlation 
between the small dense LDL and PAI-1 plasma levels in 
obese nondiabetic patients (Somodi et al., 2018; Väisänen 
et al., 1997). These data support the association between 
LDL-C and PAI-1 levels in accelerating atherogenesis and 
increasing the cardiovascular risk of obese patients; 
however, our hypothesis needs to be verified by further 
investigation. However, the correlation between HDL and 
plasma PAI-1 levels are not well understood. Also, there 
have been few studies on the correlations of PAI-1 with 
the functional and structural properties of different 
lipoprotein fractions especially on rats modeled NAFLD. 
 We were not able to evaluate the long-term effects of 
SCBG administration on the hemostasis status and lipid 
profiles in rats modeled NAFLD, as our intervention lasted 
4 weeks. Given these limitations and our findings, we 
believe that additional studies with longer intervention 
periods are warranted to determine the long-term benefits 
of SCBG consumption on the hemostasis status and lipid 
profiles in rats modeled NAFLD. However, further studies 
are needed to elucidate the underlying mechanisms. 
 
CONCLUSION 
 The administration of Single Clove Black Garlic  
450 mg; 900 mg, and 1350 mg per 200 gram BW for  
4 weeks, respectively, affected the changes in body 
weight, PAI-1 levels, and lipid profile, compared to the 
healthy and NAFLD rats. The 1350 mg per 200 g BB of 
Single Clove Black Garlic is an effective dose that reduced 
PAI-1 levels and lipid profiles, which are equivalent to  
15 grams per day when consumed by humans. More 
studies are needed in humans if Single Clove Black Garlic 
will be used as a food supplement in NAFLD. 
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